Apyx Medical Corporation (APYX)
undefined
undefined%
At close: undefined
1.68
0.30%
After-hours Dec 13, 2024, 04:00 PM EST

Company Description

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide.

The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM).

It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures.

The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market.

It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories.

The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019.

Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Apyx Medical Corporation
Apyx Medical Corporation logo
Country United States
IPO Date Jan 2, 2019
Industry Medical - Devices
Sector Healthcare
Employees 252
CEO Charles D. Goodwin II

Contact Details

Address:
5115 Ulmerton Road
Clearwater, Florida
United States
Website https://www.apyxmedical.com

Stock Details

Ticker Symbol APYX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000719135
CUSIP Number 03837C106
ISIN Number US03837C1062
Employer ID 11-2644611
SIC Code 3841

Key Executives

Name Position
Charles D. Goodwin II President, Chief Executive Officer & Director
Matthew C. Hill CPA Chief Financial Officer, Treasurer & Secretary
Moshe Citronowicz Senior Vice President
Stavros George Vizirgianakis B.Com. Executive Chairman
Todd Hornsby Executive Vice President

Latest SEC Filings

Date Type Title
Nov 08, 2024 10-Q Quarterly Report
Nov 08, 2024 424B5 Filing
Nov 08, 2024 8-K Current Report
Oct 31, 2024 SC 13G Statement of acquisition of beneficial ownership b...
Oct 15, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 13, 2024 4 Filing
Aug 12, 2024 4 Filing
Aug 12, 2024 4 Filing
Aug 12, 2024 4 Filing
Aug 12, 2024 4 Filing